Sign In
Buy IMAB
$4.63
+0 (+0%)
At Close: Apr 14, 2026
The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals
02:53pm, Friday, 13'th Mar 2020
The following are the latest biotech announcements from late Thursday and Friday morning on the development of products targeting the coronavirus.
I-Mab ADR (NASDAQ: IMAB)...
-The clinical study will explore the potential of TJM2, a proprietary mAb against GM-CSF, to fight "cytokine storm” during severe COVID-19 disease -The study to be conducted.
Coronavirus activity roundup - healthcare
11:55am, Friday, 13'th Mar 2020
The following healthcare companies have announced recent actions related to COVID-19:OPKO Health (NASDAQ:OPK): Subsidiary BioReference Laboratories is now accepting samples for COVID-19. It is also of
I-Mab to Report Financial Results for Full Year 2019 and Provide Corporate Update on March 31, 2020
12:00pm, Wednesday, 11'th Mar 2020
SHANGHAI, China and ROCKVILLE, MD., March 11, 2020 -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development.
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers
10:18pm, Monday, 02'nd Mar 2020
With one investigational cancer drug in Phase 1 testing and a second one approaching the clinic, ORIC Pharmaceuticals is looking to tap the public markets
Wells cuts view on Teladoc in premarket analyst action
01:08pm, Wednesday, 12'th Feb 2020
Ardelyx (NASDAQ:ARDX) initiated with Buy rating and $13 (75% upside) price target at Citigroup. Shares up 5% premarket.I-Mab (NASDAQ:IMAB) initiated with Buy rating and $17.93 price target at China
The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight
08:22pm, Sunday, 09'th Feb 2020
Biotech stocks recovered last week along with the broader markets, which bounced back from a China coronavirus-induced sell-off. Big pharma earnings took the spotlight, with Merck & Co., Inc. (NYSE: M
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
12:43pm, Wednesday, 05'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
12:51pm, Tuesday, 04'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie
